David Vlahov, RN, PhD, FAAN

Headshot of David Vlahov
User Profile Photo

David Vlahov, RN, PhD, FAAN

User Profile Name
Dean, UCSF School of Nursing
Professor Emeritus, School of Nursing
User Profile Title
User Profile Email

Biography

Dr. Vlahov is Professor Emeritus at the University of California, San Francisco School of Nursing after serving five years as Dean. He served on the faculty as Professor of Epidemiology at the Johns Hopkins and Columbia Universities, and was Adjunct Professor in Medical Schools at Cornell, Mount Sinai and New York University and the College of Nursing at New York University. He has also served as co-Director of the National Program Office(NPO) for the Robert Wood Johnson Foundation Health and Society Scholars program and currently, the NPO for the Foundation's Evidence for Action program. He brings research expertise in urban health, epidemiology, infectious diseases, substance abuse and mental health. Dr. Vlahov conducted studies of urban populations in Baltimore for over 20 years including several longitudinal cohort studies for which he received the NIH MERIT Award. More recently, Dr. Vlahov led epidemiologic studies in Harlem and the Bronx, which have served as a platform for subsequent individual- and community-level intervention studies and community based participatory research (involving partnerships with residents, community based organizations, academic/ public health departments) to address social determinants of health. This work has contributed information on racial/ethnic disparities in health and approaches to address such disparities. Uniting these interests, Dr. Vlahov became Director of the Center for Urban Epidemiologic Studies at the New York Academy of Medicine He was a Visiting Professor at the Medical School in Belo Horizonte, Brazil to develop their programs in urban health, and has been an expert consultant to the WHO’s Urban Health Center in Kobe, Japan. He served on the New York City Board of Health during the Bloomberg administration. Dr. Vlahov is the editor-in-chief of the Journal of Urban Health, has edited three books on urban health and published over 650 scholarly papers. With colleagues he initiated the International Society for Urban Health (www.isuh.org), serving as its first President. He is a member of the National Academy of Medicine (formerly theInstitute of Medicine) and a Fellow of the American Academy of Nursing. He has served on the Board of Directors for the American Association of Colleges of Nursing and as a member on the National Advisory Council for Nursing Education and Practice at HRSA.
CTSI Profile Bio

Displaying 526 - 550 of 679

  1. Rezza G, Pizzuti R, De Campora E, De Masi S, Vlahov D. Tetanus and injections drug use: rediscovery of a neglected problem? Eur J Epidemiol. 1996 Dec; 12(6):655-6.
  2. Comer JA, Flynn C, Regnery RL, Vlahov D, Childs JE. Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med. 1996 Nov 25; 156(21):2491-5.
  3. Solomon L, Moore J, Gleghorn A, Astemborski J, Vlahov D. HIV testing behaviors in a population of inner-city women at high risk for HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 01; 13(3):267-72.
  4. Manoff SB, Vlahov D, Herskowitz A, Solomon L, Muñoz A, Cohn S, Willoughby SB, Nelson KE. Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology. 1996 Nov; 7(6):566-70.
  5. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 01; 13(3):273-80.
  6. Latkin CA, Mandell W, Vlahov D. The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. Drug Alcohol Depend. 1996 Nov; 42(3):175-81.
  7. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis. 1996 Oct; 174(4):690-5.
  8. Markham RB, Schwartz DH, Templeton A, Margolick JB, Farzadegan H, Vlahov D, Yu XF. Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells. J Virol. 1996 Oct; 70(10):6947-54.
  9. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996 Sep 27; 273(5283):1856-62.
  10. Pezzotti P, Phillips AN, Dorrucci M, Lepri AC, Galai N, Vlahov D, Rezza G. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group. BMJ. 1996 Sep 07; 313(7057):583-6.
  11. Lukashov VV, Kuiken CL, Vlahov D, Coutinho RA, Goudsmit J. Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. AIDS Res Hum Retroviruses. 1996 Aug 10; 12(12):1179-83.
  12. Hershow RC, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, Klein RS, Des Jarlais DC, Vitek C, Khabbaz R, Freels S, Zuckerman R, Pezzotti P, Kaplan JE. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis. 1996 Aug; 174(2):309-17.
  13. Goletti D, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, Munsiff SS, Ortona L, Cauda R, Fauci AS. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol. 1996 Aug 01; 157(3):1271-8.
  14. Manoff SB, Farzadegan H, Muñoz A, Astemborski JA, Vlahov D, Rizzo RT, Solomon L, Graham NM. The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. J Infect Dis. 1996 Aug; 174(2):299-308.
  15. Smit E, Graham NM, Tang A, Flynn C, Solomon L, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition. 1996 Jul-Aug; 12(7-8):496-501.
  16. Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. Am J Community Psychol. 1996 Jun; 24(3):341-64.
  17. Galai N, Margolick JB, Astemborski J, Vlahov D. Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users. Clin Immunol Immunopathol. 1996 May; 79(2):134-41.
  18. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996 May; 86(5):655-61.
  19. Graham NM, Galai N, Nelson KE, Astemborski J, Bonds M, Rizzo RT, Sheeley L, Vlahov D. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med. 1996 Apr 22; 156(8):889-94.
  20. Crum RM, Galai N, Cohn S, Celentano DD, Vlahov D. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis. Alcohol Clin Exp Res. 1996 Apr; 20(2):364-71.
  21. Shah SM, Shapshak P, Rivers JE, Stewart RV, Weatherby NL, Xin KQ, Page JB, Chitwood DD, Mash DC, Vlahov D, McCoy CB. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 01; 11(3):301-6.
  22. Levine OS, Vlahov D, Brookmeyer R, Cohn S, Nelson KE. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis. 1996 Mar; 173(3):579-83.
  23. Zwahlen M, Vlahov D, Hoover DR. Re: "Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study" and "Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991". Am J Epidemiol. 1996 Mar 01; 143(5):523-5; author reply 525-6.
  24. Galai N, Lepri AC, Vlahov D, Pezzotti P, Sinicco A, Rezza G. Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. Am J Epidemiol. 1996 Feb 01; 143(3):278-82.
  25. Herskowitz A, Willoughby SB, Vlahov D, Baughman KL, Ansari AA. Dilated heart muscle disease associated with HIV infection. Eur Heart J. 1995 Dec; 16 Suppl O:50-5.